Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01815034 · ClinicalTrials.gov registry record
Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT01815034 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 50 participants.
The verdict
NCT01815034 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Use of trancutaneous CO2 (TC02) monitoring to aide in titration of sedation of midazolam and fentanyl. Trancutaneous readings validated with invasively obtained specimens from existing arterial sheaths required during AF and VT ablations (trans-septal and retrograde aortic respectively)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01815034
The ClinicalTrials.gov registry entry for NCT01815034 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01815034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01815034 about?
NCT01815034 is a clinical study titled "Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations". Use of trancutaneous CO2 (TC02) monitoring to aide in titration of sedation of midazolam and fentanyl. Trancutaneous readings validated with invasively obtained specimens from existing arterial sheaths required during AF and VT ablations (trans-septal and retrograde aortic respectively)
What is the current status of trial NCT01815034?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-03. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01815034?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.